These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12692364)

  • 1. Pityriasis rosea-like eruption due to pneumococcal vaccine in a child with nephrotic syndrome.
    Sasmaz S; Karabiber H; Boran C; Garipardic M; Balat A
    J Dermatol; 2003 Mar; 30(3):245-7. PubMed ID: 12692364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pityriasis rosea-like eruption due to ergotamine: a case report.
    Aydogan K; Karadogan SK; Adim SB; Tunali S
    J Dermatol; 2005 May; 32(5):407-9. PubMed ID: 16043908
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent pityriasis rosea: A case report.
    Li A; Li P; Li Y; Li W
    Hum Vaccin Immunother; 2018 Apr; 14(4):1024-1026. PubMed ID: 29182459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic features of pityriasis rosea-like drug eruption secondary to imatinib: A case report and review of the literature.
    Durgin JS; Whittington CP; Harrell J; Mervak JE; Smith EH
    J Cutan Pathol; 2024 Nov; 51(11):860-865. PubMed ID: 39021288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pityriasis rosea-like eruption induced by isotretinoin.
    Gürel G; Şahin S; Çölgeçen E
    Cutan Ocul Toxicol; 2018 Mar; 37(1):100-102. PubMed ID: 28359163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysaccharide pneumococcal vaccination of nephrotic children at disease onset-long-term data.
    Aoun B; Wannous H; Azéma C; Ulinski T
    Pediatr Nephrol; 2010 Sep; 25(9):1773-4. PubMed ID: 20238227
    [No Abstract]   [Full Text] [Related]  

  • 7. Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center.
    Atzori L; Pinna AL; Ferreli C; Aste N
    Dermatol Online J; 2006 Jan; 12(1):1. PubMed ID: 16638369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic tonguelike presentation in a child with pityriasis rosea: Case report and review of oral manifestations of pityriasis rosea.
    Alzahrani NA; AlJasser MI
    Pediatr Dermatol; 2018 Mar; 35(2):e124-e127. PubMed ID: 29436009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized pityriasis rosea.
    Ahmed I; Charles-Holmes R
    Clin Exp Dermatol; 2000 Nov; 25(8):624-6. PubMed ID: 11167977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies.
    Boef AGC; van der Klis FRM; Berbers GAM; Buisman AM; Sanders EAM; Kemmeren JM; van der Ende A; de Melker HE; Rots NY; Knol MJ
    Vaccine; 2018 Jan; 36(3):400-407. PubMed ID: 29223483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
    Valk B; Bender B
    Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pityriasis-rosea-like eruption following smallpox vaccination.
    WITHERSPOON FG; THIBODAUX DJ
    AMA Arch Derm; 1957 Jul; 76(1):109-10. PubMed ID: 13434484
    [No Abstract]   [Full Text] [Related]  

  • 13. Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases.
    Brazzelli V; Prestinari F; Roveda E; Barbagallo T; Bellani E; Vassallo C; Orlandi E; Passamonti F; Borroni G
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S240-3. PubMed ID: 16227099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gestational Pityriasis Rosea: Suggestions for Approaching Affected Pregnant Women.
    Monastirli A; Pasmatzi E; Badavanis G; Tsambaos D
    Acta Dermatovenerol Croat; 2016 Dec; 24(4):312-313. PubMed ID: 28128088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome.
    Liakou CD; Askiti V; Mitsioni A; Stefanidis CJ; Theodoridou MC; Spoulou VI
    Vaccine; 2014 Mar; 32(12):1394-7. PubMed ID: 24486348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of protective pneumococcal antibody following vaccination in patients with the nephrotic syndrome.
    Tejani A; Fikrig S; Schiffman G; Gurumurthy K
    Am J Nephrol; 1984; 4(1):32-7. PubMed ID: 6731497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pityriasis rosea-like drug reaction to asenapine.
    Makdisi J; Amin B; Friedman A
    J Drugs Dermatol; 2013 Sep; 12(9):1050-1. PubMed ID: 24002155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pityriasis rosea-like drug eruption due to nortriptyline in a patient with vulvodynia.
    Bangash HK; Finch T; Petronic-Rosic V; Sethi A; Abramsohn E; Lindau ST
    J Low Genit Tract Dis; 2013 Apr; 17(2):226-9. PubMed ID: 23343697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pityriasis rosea-like eruption associated with clozapine: a case report.
    Lai YW; Chou CY; Shen WW; Lu ML
    Gen Hosp Psychiatry; 2012; 34(6):703.e5-7. PubMed ID: 22516218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature.
    Drago F; Ciccarese G; Javor S; Parodi A
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):544-5. PubMed ID: 25545307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.